High Lung Allocation Score Is Associated With Increased Morbidity and Mortality Following Transplantation
High Lung Allocation Score Is Associated With Increased Morbidity and Mortality Following Transplantation
复制标题
DOI:
10.1378/chest.09-0319
复制
发表时间:
2010-03-01
期刊:
影响因子:
9.6
通讯作者:
Sonett, Joshua R.
中科院分区:
文献类型:
--
作者:
Russo, Mark J.;Iribarne, Alexander;Sonett, Joshua R.
Background: The lung allocation score (LAS) was initiated in May 2005 to allocate lungs based on medical urgency and posttransplant survival. The purpose of this study was to determine if there is an association between an elevated. LAS at the time of transplantation and increased postoperative morbidity and mortality.Methods: The United Network for Organ Sharing provided de-identified patient-level data. Analysis included lung transplant recipients aged >= 12 years who received transplants between April 5, 2006, and December 31, 2007 (n = 3,836). Recipients were stratified into three groups: LAS < 50 (n = 3,161, 83.87%), LAS 50 to 75 (n = 411, 10.9%), and LAS >= 75 (n = 197, 5.23%), referred to as low LAS (LLAS), intermediate LAS (ILAS), and high LAS (HLAS), respectively. The primary outcome was posttransplant graft survival at 1 year. Secondary outcomes included length of stay and in-hospital complications.Results: HLAS recipients had significantly worse actuarial survival at 90 days and I year compared with LLAS recipients. When transplant recipients were stratified by disease etiology, a trend of decreased survival with elevated LAS was observed across all major causes of lung transplant. HLAS recipients were more likely to require dialysis or to have infections compared with LLAS recipients (P